Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT06325020

Objective Risk Assessment in Patients With Possible Anginal Chest Pain Using Leading Technology

Sponsor: University of Edinburgh

View on ClinicalTrials.gov

Summary

The ORACLE study is an observational cohort study designed to explore the feasibility of providing an assessment of chest pain for patients with suspected angina within one working day of referral to specialist services. The primary objective is to determine the feasibility of delivering an objective assessment of risk for participants who have been referred by their primary care provider to the rapid access chest pain clinic with possible angina in a community setting using point of care and patient facing technologies within one working day of referral. Participants will complete a digital health questionnaire, at home, that asks about their risk factors for coronary artery disease, past medical history and their symptoms. Patients will then have a standard 12 lead ECG and perform their own personal ECG. They will then have high sensitivity cardiac troponin measured by point of care high sensitivity cardiac troponin assays as well as a core lab assay. The results of all of the above will allow patients to be started as low, intermediate or high risk for future cardiovascular events.

Official title: ORACLE: Objective Risk Assessment in Patients With Possible Anginal Chest Pain Using Leading Technology

Key Details

Gender

All

Age Range

30 Years - Any

Study Type

OBSERVATIONAL

Enrollment

500

Start Date

2024-07-04

Completion Date

2026-12-31

Last Updated

2026-04-07

Healthy Volunteers

No

Interventions

OTHER

The assessment of patients with possible angina using the ORACLE pathway

Participants will complete a digital health questionnaire, at home, that asks about their risk factors for coronary artery disease, past medical history and their symptoms. Patients will then have a standard 12 lead ECG and perform their own personal ECG. They will then have high sensitivity cardiac troponin measured. The results of all of the above will allow patients to be started as low, intermediate or high risk for future cardiovascular events.

Locations (1)

NHS Lothian

Edinburgh, United Kingdom